Atossa Therapeutics (ATOS) vs TherapeuticsMD (TXMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
TherapeuticsMD (TXMD) has outperformed Atossa Therapeutics (ATOS) over the past year, gaining 85.2% versus a loss of 83.8%. Over five years, ATOS leads with a -94.3% price change compared with -94.4% for TXMD. Atossa Therapeutics is the larger company by market cap ($24.1 million vs $23.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ATOS | TXMD |
|---|---|---|
| Share price | $2.42 | $2.01 |
| Market cap | $24.15M | $23.26M |
| 1-day change | -1.63% | +0.50% |
| YTD return | -72.20% | +22.70% |
| 1-year return | -83.76% | +85.19% |
| 5-year return | -94.27% | -94.44% |
| Forward P/E | — | 5.74 |
| EPS (TTM) | $-4.45 | $-0.04 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $19.35 | $2.95 |
| 52-week low | $1.70 | $1.03 |
| Distance from 52-week high | -87.49% | -31.86% |
| Average volume | 64.15K | 23.94K |
| Shares outstanding | 9.98M | 11.57M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TXMD has outperformed ATOS by 168.9 percentage points over the past year.
ATOS vs TXMD FAQ
Which is bigger, Atossa Therapeutics or TherapeuticsMD?
Atossa Therapeutics (ATOS) is larger, with a market capitalization of $24.15M compared with $23.26M for TherapeuticsMD (TXMD).
Which stock has performed better over the past year, ATOS or TXMD?
TXMD returned +85.19% over the past 12 months, compared with -83.76% for ATOS (price return, excluding dividends). Past performance does not predict future results.
Are Atossa Therapeutics and TherapeuticsMD in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.